Fair price Eagle Pharmaceuticals, Inc.
Price based on EPS
Price = EPS * (1 + CAGR EPS) / (Key Rate * Excess Key Rate)
Key Rate = Key rate
Fair price = 0.8701 $
Current price = 0.33 $ (difference = +163.68%)
Data
Discounted Cash Flow (Based EBITDA)
Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value β cost in the post-forecast period
Company Value β cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = β (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 178.52 $
Current price = 0.33 $ (difference = +53 997.8%)
Data
Discounted Cash Flow (Based FCF)
Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value β cost in the post-forecast period
Company Value β cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = β (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 16.57 $
Current price = 0.33 $ (difference = +4 922.08%)
Data
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Based on sources: porti.ru

